[14C]-CORT113176 Clinical Trials (2026): 3 Studies for Healthy Adults & Healthy
Hipa.ai Research · Source: ClinicalTrials.gov / AACT
Synced daily from ClinicalTrials.gov via AACT. Last sync: .
3 [14C]-CORT113176 clinical trials are catalogued on Hipa.ai from the AACT mirror of ClinicalTrials.gov, spanning 2 indications (including Healthy Adults & Healthy) and 132 total planned enrollment. Most recent activity: NCT04994743 (Sep 2021).
[14C]-CORT113176 clinical trials at a glance: phase × recruitment status
| Phase | completed | Total |
|---|---|---|
| P1 | 3 | 3 |
[14C]-CORT113176 clinical trials by indication
Healthy Adults (2)
| NCT | Acronym | Phase | Status | Title |
|---|---|---|---|---|
| NCT04994743 | — | P1 | completed | Safety, Tolerability, and Pharmacokinetic Study of CORT113176 in Healthy Participants |
| NCT04249323 | — | P1 | completed | Single and Multiple Ascending Dose Study of CORT113176 in Healthy Participants |
Healthy (1)
| NCT | Acronym | Phase | Status | Title |
|---|---|---|---|---|
| NCT04990310 | — | P1 | completed | Single Dose Absorption, Distribution, Metabolism, and Excretion Study of [14C]-CORT113176 in Healthy Male Participants |
All [14C]-CORT113176 trials (3)
Sorted by most recent activity (completion → start → posted date). Each row links to the trial detail page on Hipa.ai.
| NCT ID | Acronym | Title | Phase | Status | Enrollment | Sponsor | Started |
|---|---|---|---|---|---|---|---|
| NCT04994743 | Safety, Tolerability, and Pharmacokinetic Study of CORT113176 in Healthy Participants | P1 | completed | 16 | Corcept Therapeutics | Jul 2021 | |
| NCT04990310 | Single Dose Absorption, Distribution, Metabolism, and Excretion Study of [14C]-CORT113176 in Healthy Male Participants | P1 | completed | 6 | Corcept Therapeutics | Aug 2021 | |
| NCT04249323 | Single and Multiple Ascending Dose Study of CORT113176 in Healthy Participants | P1 | completed | 110 | Corcept Therapeutics | Jan 2020 |
[14C]-CORT113176 clinical trials: frequently asked questions
- How many [14C]-CORT113176 clinical trials are there?
- 3 [14C]-CORT113176 clinical trials are catalogued on Hipa.ai, sourced from the AACT mirror of ClinicalTrials.gov. 3 are marked completed.
- Are [14C]-CORT113176 clinical trials recruiting in 2026?
- No active [14C]-CORT113176 trials are recruiting on ClinicalTrials.gov as of the current AACT refresh. Trials may resume; this page is updated daily.
- What conditions is [14C]-CORT113176 being studied for?
- [14C]-CORT113176 is being studied for Healthy Adults, Healthy. The trials are grouped by indication on this page.
- What phase is [14C]-CORT113176 in?
- [14C]-CORT113176 clinical trials span 3 Phase 1. The phase × status matrix at the top of this page breaks down counts by phase and recruitment status.
- Who sponsors [14C]-CORT113176 clinical trials?
- The lead sponsor across the most [14C]-CORT113176 trials is Corcept Therapeutics. Each trial row links to the full study detail page including sponsor information.
Sources and methodology
Trial inventory derived from the AACT mirror of ClinicalTrials.gov. Trials are filtered to those naming [14C]-CORT113176as an intervention. Phase, status, enrollment, sponsor, and dates are taken from the source `studies` table; primary indication is the first listed condition. Acronyms are extracted from each trial's brief title where present. PubMed links are populated for trials whose published primary outcomes have been indexed in our evidence cache.
Last refreshed .
Related pages on Hipa.ai: